Biologics & Pharmaceutical Patent Litigation Prescribed Solutions
In order to succeed in the ever-competitive pharmaceutical marketplace, generic pharmaceutical and drug development companies require legal counsel with a deep understanding of the Hatch-Waxman Act, BPCIA, and related statutes; extensive patent law experience; and unique insight into a company’s technology. At Kilpatrick Townsend, our specially-assembled litigation team brings a fresh approach when handling biologics and pharmaceutical patent litigation, having successfully represented some of the world’s largest generic pharmaceutical companies. Our team includes former scientists, engineers, patent examiners, and federal law clerks — many with vast pharmaceutical industry experience as regulators, developers, trial designers, marketing managers, and in-house attorneys — giving us keen business insight to provide well-rounded client results. Our services span the gamut of pharmaceutical-related patent litigation — including pre-litigation due diligence, analysis, patent validity and infringement opinion preparation, Paragraph IV letters, and federal pharmaceutical patent litigation. Many of our litigators bring a long and successful history litigating patent and Hatch-Waxman matters in all jurisdictions, including numerous cases in Delaware and New Jersey — the predominant venues for Hatch-Waxman litigation and the corporate headquarters for many pharmaceutical companies.
patent litigation cases in the past 5 years, including 173 before the PTAB
attorneys and staff with advance degrees in various scientific or engineering disciplines
Litigation - Patent Law
U.S. News - Best Lawyers® “Best Law Firms” (2018)
Kilpatrick Townsend Counsel to Leaders
Meet The Team View All
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.